🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Determine the effect of a single instillation of NOV03 on the thickness and...
Status
Completed
Location
Site 101
Start Date
2023-08-14
Trial ID
NCT05723770
Treatments Being Tested
A Randomized, Multicenter, Double-Masked, Saline-Controlled Trial to Evalua...
Status
Active Not Recruiting
Location
Site 101
Start Date
2024-07-31
Trial ID
NCT06565650
Assess the impact of concomitant Miebo use while wearing contact lenses...
Status
Completed
Location
Site 101
Start Date
2025-07-02
Trial ID
NCT07054606
Treatments Being Tested
A Study to Assess the Long-Term Safety of Lifitegrast/Perfluorohexyloctane ...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-12
Trial ID
NCT07111013
Treatments Being Tested
Miebo (Perfluorohexyloctane) is a novel, non-aqueous, single entity, preser...
Status
Completed
Location
Gordon Schanzlin New Vision Institute
Start Date
2023-09-21
Trial ID
NCT06176651
Treatments Being Tested
A 4-Week, Randomized, Double-Masked, Parallel-Group, Active-Controlled, Mul...
Status
Completed
Location
Eye Doctors of Arizona, PLLC
Start Date
2025-10-24
Trial ID
NCT07128628
A Phase 4, Multicenter, Open-Label Study to Evaluate the Effect of Miebo™ o...
Status
Completed
Location
Site 105
Start Date
2024-04-30
Trial ID
NCT06346340
Treatments Being Tested
This PMCF study is carried out following successful CE marking of NovaTears...
Status
Completed
Location
NTO-001 Investigational Site
Start Date
2020-11-09
Trial ID
NCT04521465
Treatments Being Tested
The objectives of this trial are to evaluate the safety and tolerability of...
Status
Completed
Location
Bausch Site 124
Start Date
2020-09-24
Trial ID
NCT04140227
Treatments Being Tested
The purpose of this study is to explore the tear lipid layer quantitatively...
Status
Completed
Location
The Ohio State University College of Optometry
Start Date
2022-03-27
Trial ID
NCT05288582
Treatments Being Tested